Equity Method Income
ResMed Equity Method Income increased by 13.4% to $1.72M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 412.8%, from $335.00K to $1.72M. Over 3 years (FY 2021 to FY 2025), Equity Method Income shows an upward trend with a -31.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase reflects strong performance from joint ventures or strategic partners, while a decrease indicates underperformance in those specific investments.
Detailed definition
This metric captures the company's proportionate share of the net earnings or losses from investments in unconsolidated...
Peer comparison
Common in technology and manufacturing sectors where joint ventures are used for R&D or supply chain integration.
equity_method_incomeHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$1.31M | -$1.39M | -$1.91M | -$2.63M | -$2.56M | -$2.03M | -$2.83M | -$183.00K | -$2.23M | -$3.90M | $739.00K | $440.00K | $963.00K | $1.08M | $335.00K | $1.27M | $1.49M | $1.52M | $1.72M |
| QoQ Change | — | -6.0% | -38.1% | -37.3% | +2.6% | +20.8% | -39.3% | +93.5% | <-999% | -74.8% | +119.0% | -40.5% | +118.9% | +11.8% | -68.9% | +278.8% | +17.3% | +1.7% | +13.4% |
| YoY Change | — | — | — | — | -95.6% | -46.3% | -47.6% | +93.0% | +12.9% | -92.1% | +126.2% | +340.4% | +124.7% | +45.7% | -23.9% | — | +54.6% | +40.7% | +412.8% |
Equity Method Income at Other Companies
Frequently Asked Questions
- What is ResMed's equity method income?
- ResMed (RMD) reported equity method income of $1.72M in Q1 2026.
- How has ResMed's equity method income changed year-over-year?
- ResMed's equity method income increased by 412.8% year-over-year, from $335.00K to $1.72M.
- What is the long-term trend for ResMed's equity method income?
- Over 3 years (2021 to 2025), ResMed's equity method income has grown at a -31.2% compound annual growth rate (CAGR), from -$11.21M to $3.64M.
- What does equity method income mean?
- The company's share of profits or losses from businesses it partially owns.